Chenglong Xie - Concepedia

Author

Chenglong Xie

Also Known As

C. Xie, C.Y. Xie, Cheng-Long Xie, Cheng-long Xie, Chenglong Xie, Cheng‑Long Xie, Chi-Yang Xie, Chiyang Xie, Chunya Xie, Z. Zhang

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Wenzhou Medical University First Affiliated Hospital of Wenzhou Medical University Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University University of Oslo Akershus University Hospital

About

Chenglong Xie is an author at Wenzhou Medical University specializing in medicine, neuroscience, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	123
2	Neurology	5	5	123
3	Social Sciences	2	2	40
4	Health Sciences	1	1	14
5	Metabolism	1	1	25

Chenglong Xie

Publications

712

Citations

H-Index

Page 1

	Year	Citations
Amelioration of Alzheimer’s disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow Chenglong Xie, Xu‐Xu Zhuang, Zhangming Niu, Nature Biomedical Engineering	2022	316
Administration of quercetin improves mitochondria quality control and protects the neurons in 6-OHDA-lesioned Parkinson's disease models Wenwen Wang, Ruiyu Han, Haijun He, Aging	2021	115
Metformin Promotes the Survival of Random-Pattern Skin Flaps by Inducing Autophagy via the AMPK-mTOR-TFEB signaling pathway Hongqiang Wu, Jian Ding, Shihen Li, International Journal of Biological Sciences	2019	61
Neuroprotective effects of curcumin via autophagy induction in 6-hydroxydopamine Parkinson's models Haijun He, Xi Xiong, Shuoting Zhou, Neurochemistry International Cell AutophagyMitophagyAutophagy InductionMedicineAutophagy	2022	48
Brain-Region Specific Metabolic Abnormalities in Parkinson’s Disease and Levodopa-Induced Dyskinesia Changwei Yang, Tingting Zhang, Wuqiong Wang, Frontiers in Aging Neuroscience Neurological DisorderMetabolomic ProfilingNeurochemical BiomarkersSocial SciencesNeurobiology Of Disease	2020	25
Lipoic acid alleviates L‑DOPA‑induced dyskinesia in 6‑OHDA parkinsonian rats via anti‑oxidative stress Sufang Zhang, Chenglong Xie, Jingya Lin, Molecular Medicine Reports PharmacotherapyExperimental PharmacologyRat ModelOxidative StressMolecular Pharmacology	2017	21
NAD+-boosting agent nicotinamide mononucleotide potently improves mitochondria stress response in Alzheimer’s disease via ATF4-dependent mitochondrial UPR Xi Xiong, Jialong Hou, Yi Zheng, Cell Death and Disease	2024	19
Lewy Body-Associated Proteins A-Synuclein (a-syn) as a Plasma-Based Biomarker for Parkinson’s Disease Xuemiao Zhao, Haijun He, Xi Xiong, Frontiers in Aging Neuroscience	2022	18
Alzheimer's disease diagnostic accuracy by fluid and neuroimaging <scp>ATN</scp> framework Xi Xiong, Haijun He, Qianqian Ye, CNS Neuroscience & Therapeutics	2023	16
Modulation of CaMKIIa-GluN2B interaction in levodopa-induced dyskinesia in 6-OHDA-lesioned Parkinson’s rats Xinshi Wang, Zengrui Zhang, Xingru Zhang, Biomedicine & Pharmacotherapy Camkiia-glun2b InteractionNeurodegenerative DiseasesMolecular NeuroscienceNeurophysiologyMedicine	2018	15

Page 1